Global Human Microbiome Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch＇s in-depth investigation and research, the global Human Microbiome market size will reach 719.57 Million USD in 2025 and is projected to reach 2,420.23 Million USD by 2032, with a CAGR of 18.92% (2025-2032). Notably, the China Human Microbiome market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
The human microbiome refers to the diverse and complex community of microorganisms, including bacteria, viruses, fungi, and other microbes, that inhabit various parts of the human body, such as the skin, mouth, gut, and other mucosal surfaces. This microbial ecosystem plays a crucial role in maintaining health by contributing to digestion, nutrient absorption, immune system development, and protection against harmful pathogens. The composition of the human microbiome is highly individualized, influenced by factors such as genetics, diet, environment, and lifestyle. Imbalances in the microbiome, known as dysbiosis, have been linked to various health conditions, including autoimmune diseases, gastrointestinal disorders, and metabolic disorders. Ongoing research in microbiome science is uncovering the intricate relationships between the microbiome and human health, with potential implications for personalized medicine and therapeutic interventions.
The major global suppliers of Human Microbiome include Vedanta, Seres Therapeutics, Second Genome, Rebiotix, ActoGeniX, Enterome BioScience, AvidBiotics, 4D Pharma Research Ltd, Enterologics, Metabogen, Ritter Pharmaceuticals, Metabiomics, Osel, Symberix, Miomics, Symbiotix Biotherapies, MicroBiome Therapeutics LLC, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Human Microbiome. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Human Microbiome market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Human Microbiome market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Human Microbiome industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Human Microbiome Include:
Vedanta
Seres Therapeutics
Second Genome
Rebiotix
ActoGeniX
Enterome BioScience
AvidBiotics
4D Pharma Research Ltd
Enterologics
Metabogen
Ritter Pharmaceuticals
Metabiomics
Osel
Symberix
Miomics
Symbiotix Biotherapies
MicroBiome Therapeutics LLC
Human Microbiome Product Segment Include:
Gastrointestinal Tract Human Micobiome
Urogenital Tract Human Micobiome
Others
Human Microbiome Product Application Include:
Treatment
Diagnosis
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Human Microbiome Industry PESTEL Analysis
Chapter 3: Global Human Microbiome Industry Porter's Five Forces Analysis
Chapter 4: Global Human Microbiome Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Human Microbiome Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Human Microbiome Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Human Microbiome Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch＇s in-depth investigation and research, the global Human Microbiome market size will reach 719.57 Million USD in 2025 and is projected to reach 2,420.23 Million USD by 2032, with a CAGR of 18.92% (2025-2032). Notably, the China Human Microbiome market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
The human microbiome refers to the diverse and complex community of microorganisms, including bacteria, viruses, fungi, and other microbes, that inhabit various parts of the human body, such as the skin, mouth, gut, and other mucosal surfaces. This microbial ecosystem plays a crucial role in maintaining health by contributing to digestion, nutrient absorption, immune system development, and protection against harmful pathogens. The composition of the human microbiome is highly individualized, influenced by factors such as genetics, diet, environment, and lifestyle. Imbalances in the microbiome, known as dysbiosis, have been linked to various health conditions, including autoimmune diseases, gastrointestinal disorders, and metabolic disorders. Ongoing research in microbiome science is uncovering the intricate relationships between the microbiome and human health, with potential implications for personalized medicine and therapeutic interventions.
The major global suppliers of Human Microbiome include Vedanta, Seres Therapeutics, Second Genome, Rebiotix, ActoGeniX, Enterome BioScience, AvidBiotics, 4D Pharma Research Ltd, Enterologics, Metabogen, Ritter Pharmaceuticals, Metabiomics, Osel, Symberix, Miomics, Symbiotix Biotherapies, MicroBiome Therapeutics LLC, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Human Microbiome. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Human Microbiome market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Human Microbiome market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Human Microbiome industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Human Microbiome Include:
Vedanta
Seres Therapeutics
Second Genome
Rebiotix
ActoGeniX
Enterome BioScience
AvidBiotics
4D Pharma Research Ltd
Enterologics
Metabogen
Ritter Pharmaceuticals
Metabiomics
Osel
Symberix
Miomics
Symbiotix Biotherapies
MicroBiome Therapeutics LLC
Human Microbiome Product Segment Include:
Gastrointestinal Tract Human Micobiome
Urogenital Tract Human Micobiome
Others
Human Microbiome Product Application Include:
Treatment
Diagnosis
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Human Microbiome Industry PESTEL Analysis
Chapter 3: Global Human Microbiome Industry Porter's Five Forces Analysis
Chapter 4: Global Human Microbiome Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Human Microbiome Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Human Microbiome Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Human Microbiome Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Human Microbiome Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Human Microbiome Product by Type
- 1.2.1 Gastrointestinal Tract Human Micobiome
- 1.2.2 Urogenital Tract Human Micobiome
- 1.2.3 Others
- 1.3 Human Microbiome Product by Application
- 1.3.1 Treatment
- 1.3.2 Diagnosis
- 1.4 Global Human Microbiome Market Size Analysis (2020-2032)
- 1.5 Human Microbiome Market Development Status and Trends
- 1.5.1 Human Microbiome Industry Development Status Analysis
- 1.5.2 Human Microbiome Industry Development Trends Analysis
- 2 Human Microbiome Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Human Microbiome Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Human Microbiome Market Analysis by Country
- 4.1 Global Human Microbiome Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Human Microbiome Revenue Analysis by Country (2020-2025)
- 4.1.2 Global Human Microbiome Revenue Forecast Analysis by Country (2026-2032)
- 4.2 United States Human Microbiome Market Revenue and Growth Rate (2020-2032)
- 4.3 Germany Human Microbiome Market Revenue and Growth Rate (2020-2032)
- 4.4 Japan Human Microbiome Market Revenue and Growth Rate (2020-2032)
- 4.5 China Human Microbiome Market Revenue and Growth Rate (2020-2032)
- 4.6 France Human Microbiome Market Revenue and Growth Rate (2020-2032)
- 4.7 U.K. Human Microbiome Market Revenue and Growth Rate (2020-2032)
- 4.8 South Korea Human Microbiome Market Revenue and Growth Rate (2020-2032)
- 4.9 Canada Human Microbiome Market Revenue and Growth Rate (2020-2032)
- 4.10 Italy Human Microbiome Market Revenue and Growth Rate (2020-2032)
- 4.11 Russia Human Microbiome Market Revenue and Growth Rate (2020-2032)
- 4.12 Mexico Human Microbiome Market Revenue and Growth Rate (2020-2032)
- 4.13 Brazil Human Microbiome Market Revenue and Growth Rate (2020-2032)
- 4.14 India Human Microbiome Market Revenue and Growth Rate (2020-2032)
- 4.15 Vietnam Human Microbiome Market Revenue and Growth Rate (2020-2032)
- 4.16 Thailand Human Microbiome Market Revenue and Growth Rate (2020-2032)
- 4.17 South Africa Human Microbiome Market Revenue and Growth Rate (2020-2032)
- 5 Competition by Suppliers
- 5.1 Global Human Microbiome Market Revenue by Key Suppliers (2021-2025)
- 5.2 Human Microbiome Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Human Microbiome Competitive Landscape Analysis
- 5.2.2 Global Key Suppliers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Human Microbiome Market Analysis by Type
- 6.1 Global Human Microbiome Market Size Analysis by Type: 2024 VS 2025 VS 2032
- 6.2 Global Human Microbiome Revenue and Forecast Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Vedanta
- 7.1.1 Vedanta Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Vedanta Human Microbiome Product Portfolio
- 7.1.3 Vedanta Human Microbiome Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.2 Seres Therapeutics
- 7.2.1 Seres Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Seres Therapeutics Human Microbiome Product Portfolio
- 7.2.3 Seres Therapeutics Human Microbiome Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.3 Second Genome
- 7.3.1 Second Genome Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 Second Genome Human Microbiome Product Portfolio
- 7.3.3 Second Genome Human Microbiome Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.4 Rebiotix
- 7.4.1 Rebiotix Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 Rebiotix Human Microbiome Product Portfolio
- 7.4.3 Rebiotix Human Microbiome Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.5 ActoGeniX
- 7.5.1 ActoGeniX Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 ActoGeniX Human Microbiome Product Portfolio
- 7.5.3 ActoGeniX Human Microbiome Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.6 Enterome BioScience
- 7.6.1 Enterome BioScience Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 Enterome BioScience Human Microbiome Product Portfolio
- 7.6.3 Enterome BioScience Human Microbiome Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.7 AvidBiotics
- 7.7.1 AvidBiotics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 AvidBiotics Human Microbiome Product Portfolio
- 7.7.3 AvidBiotics Human Microbiome Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.8 4D Pharma Research Ltd
- 7.8.1 4D Pharma Research Ltd Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 4D Pharma Research Ltd Human Microbiome Product Portfolio
- 7.8.3 4D Pharma Research Ltd Human Microbiome Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.9 Enterologics
- 7.9.1 Enterologics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 Enterologics Human Microbiome Product Portfolio
- 7.9.3 Enterologics Human Microbiome Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.10 Metabogen
- 7.10.1 Metabogen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.10.2 Metabogen Human Microbiome Product Portfolio
- 7.10.3 Metabogen Human Microbiome Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.11 Ritter Pharmaceuticals
- 7.11.1 Ritter Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.11.2 Ritter Pharmaceuticals Human Microbiome Product Portfolio
- 7.11.3 Ritter Pharmaceuticals Human Microbiome Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.12 Metabiomics
- 7.12.1 Metabiomics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.12.2 Metabiomics Human Microbiome Product Portfolio
- 7.12.3 Metabiomics Human Microbiome Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.13 Osel
- 7.13.1 Osel Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.13.2 Osel Human Microbiome Product Portfolio
- 7.13.3 Osel Human Microbiome Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.14 Symberix
- 7.14.1 Symberix Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.14.2 Symberix Human Microbiome Product Portfolio
- 7.14.3 Symberix Human Microbiome Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.15 Miomics
- 7.15.1 Miomics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.15.2 Miomics Human Microbiome Product Portfolio
- 7.15.3 Miomics Human Microbiome Market Data Analysis (Revenue, Gross Margin and
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
